| (EUR) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 95.02M | 7.76% |
| Operating expense | — | — |
| Net income | 36.17M | 1.50% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, UR9.F returned -9.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -4.3% |
| 1 year | -9.5% |
| 5 years | -70.1% |
| 10 years | +94.9% |
| All-time high | €25.97 (Sep 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in UR9.F would be worth today ›Yes. Clinuvel Pharmaceuticals Limited paid 1 dividend over the past 12 months. The most recent was €0.03 per share on Sep 4, 2025. The dividend yield is 0.45%.
Clinuvel Pharmaceuticals Limited is part of the Healthcare sector.
Clinuvel Pharmaceuticals Limited has a market cap of 337.67M EUR, based on the latest quote.
Clinuvel Pharmaceuticals Limited is scheduled to report earnings on Aug 27, 2026.
